EMP Metabolite Profiling Service
InquiryObesity is a complex metabolic disorder characterized by systemic dysregulation of lipid metabolism, glucose homeostasis, and energy expenditure. At Protheragen, we recognize that developing effective anti-obesity therapeutics requires more than just monitoring weight loss; it demands a deep understanding of the underlying biochemical shifts.
EMP Metabolite Profiling Service for Anti-Obesity Therapeutics
Our EMP metabolite profiling service is specifically engineered for preclinical drug development, providing high-resolution snapshots of the metabolome. By integrating advanced mass spectrometry with sophisticated bioinformatics, we empower researchers to identify metabolic signatures, validate drug targets, and elucidate the mechanisms of action for novel anti-obesity compounds, including GLP-1 agonists, lipase inhibitors, and thermogenic agents.
Core Technologies
Protheragen utilizes a state-of-the-art analytical suite to ensure the highest sensitivity and specificity in metabolite detection.
- High-Resolution Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Our platform provides untargeted and targeted profiling of polar and non-polar metabolites, ensuring comprehensive coverage of the metabolic landscape.
- Integrated Proteomic and Metabolomic Profiling
By combining these "omic" layers, we define cellular functionality and regulatory networks, identifying key enzyme-metabolite interactions critical to fat oxidation.
- Advanced Stable Isotope Tracing
This technology allows for the quantification of metabolic fluxes, tracing the fate of specific carbons through the TCA cycle and lipid biosynthetic pathways.
- Multivariate Statistical Modeling
We employ PCA, PLS-DA, and pathway enrichment analysis to extract biological meaning from complex datasets, turning raw peaks into actionable therapeutic insights.
Service Scope
Our EMP profiling covers a vast array of metabolic markers essential for anti-obesity research:
- Lipidomics
Comprehensive analysis of triglycerides, phospholipids, and sphingolipids to assess lipid storage and mobilization.
- Central Carbon Metabolism
Monitoring glycolysis, the pentose phosphate pathway, and the TCA cycle to evaluate energy efficiency.
- Amino Acid and Neurotransmitter Profiling
Investigating the role of branched-chain amino acids (BCAAs) and satiety-related metabolites.
- Gut Microbiota-Derived Metabolites
Analyzing short-chain fatty acids (SCFAs) and bile acids that influence systemic metabolic health.
Contact Our Team for More Information and to Discuss Your Project.
Workflow
The Protheragen service process is designed for precision, transparency, and rapid turnaround to support fast-paced preclinical timelines.
Fields of Application
The EMP metabolite profiling service at Protheragen provides critical biochemical intelligence across the entire preclinical development spectrum, enabling researchers to bridge the gap between initial compound screening and robust mechanistic validation.
- Mechanism of Action (MoA) Elucidation: Discover how your drug alters cellular energy expenditure and mitochondrial function.
- Biomarker Discovery: Identify early-stage metabolic indicators of drug efficacy before physical weight changes are observable.
- Toxicity and Safety Assessment: Screen for off-target metabolic effects or hepatic lipid accumulation.
- Lead Optimization: Compare different chemical analogs based on their ability to restore a "lean" metabolic profile in Obese Models.
Accelerate Your Preclinical Program with the Industry's Most Detailed Metabolic Insights.
Advantages
Protheragen stands at the forefront of metabolic phenotyping. Our EMP service offers unparalleled depth in characterizing the efficacy of anti-obesity interventions.
- Precision and Depth
We identify thousands of metabolic features, providing a granular view of the "metabolic switch" from fat storage to fat utilization.
- Preclinical Specialization
Our analytical protocols are meticulously tailored for a diverse array of animal models and sophisticated 3D cell culture systems, ensuring the data generated reflects the complex physiological environment of metabolic disease.
- High Sensitivity for Low-Abundance Markers
We detect subtle shifts in signaling lipids and hormones that are often missed by standard assays.
- Validated Reliability
In numerous studies, our profiling has successfully identified biomarkers that correlate with therapeutic weight reduction.
Customer Review
Uncovering Novel Metabolic Shifts in SIRT1 Activator Research
"Protheragen provided the metabolic clarity we needed for our SIRT1 activator program. Their EMP service identified a specific shift in fatty acid oxidation that we hadn't captured with standard assays. The depth of the report and the biological insights were instrumental in selecting our lead candidate for further development."
Dr. S. L., Obesity Drug Discovery Firm
Validating Thermogenic Mechanisms and Mitochondrial Function
"The team at Protheragen is exceptional. We were struggling to understand why our compound was causing weight loss without a reduction in caloric intake. Their profiling revealed a significant upregulation in thermogenic pathways and mitochondrial uncoupling markers. We look forward to our next collaboration on our gut-brain axis project."
Mr. P. S., Biopharma Startup
Frequently Asked Questions
-
What sample types are compatible with the EMP service?
We process plasma, serum, urine, fecal matter, and various tissues, including white/brown adipose tissue and liver.
-
How do you handle the high dynamic range of metabolites?
We use specialized normalization techniques and multiple dilution series to ensure both high-abundance lipids and low-abundance signaling molecules are quantified accurately.
-
Can this service help distinguish between fat loss and muscle loss?
Yes, by profiling amino acid catabolism and specific muscle-derived metabolites, we can provide insights into body composition changes.
-
How do you identify "unknown" metabolites?
We use an extensive internal library combined with public databases and MS/MS fragmentation patterns for high-confidence identification.
-
What is the typical turnaround time?
Most preclinical projects are completed within 4 to 6 weeks from sample receipt.
-
Do you offer custom panels for specific pathways?
Yes, we can develop targeted MRM assays for specific pathways like the GLP-1 signaling axis or cholesterol metabolism.
-
How do you ensure data reproducibility?
We implement strict QC protocols, including the use of internal standards and pooled sample injections throughout the run.
-
Can you help with the biological interpretation of the data?
Our PhD-level scientists provide a comprehensive discussion of the results in the context of your specific research goals.
Contact Us
Protheragen is your strategic partner in unlocking the metabolic secrets of anti-obesity therapeutics. Our EMP metabolite profiling service provides the high-fidelity data required to transform promising molecules into breakthrough treatments.
Contact Protheragen for More Information and to Discuss Your Project
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.